Law360, New York (January 04, 2012, 4:48 PM ET) -- Abbott Laboratories on Tuesday dropped five consolidated patent infringement suits against Teva Pharmaceuticals Industries Ltd. over Teva's attempts to market a generic version of Abbott's cholesterol drug Simcor.
According to a joint stipulation of dismissal filed in a Delaware federal court last week, the parties agreed to pay their own costs and neither admitted to liability in the two-year-old dispute. U.S. District Judge Sue Robinson signed an order dismissing the cases with prejudice Tuesday.
Abbott and Abbott Respiratory LLC lodged the most recent complaint in August...
Abbott Drops Patent Claims Over Teva's Generic Simcor
To view the full article, take a free trial now.
